17 results
8-K
EX-99.1
ANNX
Annexon Inc
13 May 24
Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones
4:05pm
to date, we are well-positioned to achieve our mission of bringing our first-in-kind therapies to millions of patients and families impacted
8-K
EX-99.1
ANNX
Annexon Inc
4 Mar 24
Regulation FD Disclosure
5:25pm
and Peripheral Nerve Society Annual Meetings 2021-2022.
Annexon Has a Deep-Rooted History and Commitment to GBS Aligned With Our Mission Strong Scientific
8-K
EX-99.1
ANNX
Annexon Inc
25 May 23
Other Events
6:08am
for patients with GA, marking an important step toward achieving our mission of delivering game-changing therapies to patients living with complement
8-K
EX-99.1
wxil3u
7 Jun 22
Other Events
4:06pm
8-K
EX-99.1
ddjyyyr
10 Jan 22
Regulation FD Disclosure
6:40am
8-K
EX-99.1
e401tq42o7
16 Aug 21
Annexon Biosciences Reports Second Quarter 2021 Financial Results and Provides Mid-Year Business Update
4:11pm
8-K
EX-99.1
r5h013m
17 May 21
Annexon Biosciences Provides Business Update and Reports First Quarter 2021 Financial Results
4:17pm
10-K
dkg8hutp
25 Mar 21
Annual report
7:16am
10-Q
rq8y4 8zoaqhjg6md
8 Sep 20
Quarterly report
5:18pm
- Prev
- 1
- Next